Vaccine evaluation, implementation and policy
13:00 Using electronic health records to evaluate the burden of RSV
This talk will present estimates of the secondary care burden of RSV in young children in England – calculated using national laboratory surveillance and hospital admission data – and discuss the implications for potential vaccine strategy
Presented by: Rachel Reeves UCL / PHE
13:20 The current situation and cost-effectiveness of prophylactic interventions against RSV
This talk will give an overview of the potential benefits and uses that vaccines and monoclonal antibiodies against RSV may have, based on preliminary disease burden and economic modelling.
Presented by: Mark Jit, LSHTM / PHE
13:40 Using mathematical models to understand the transmission dynamics of RSV
This talk will give an overview of existing mathematical models of RSV transmission. I will discuss what mathematical features are important in capturing specific epidemiological characteristics of RSV and methods of evaluating the impact of potential vaccination programmes.
Presented by: David Hodgson, UCL
Admission